MR. THOMAS NATHAN HOFFMANN (M.D.) – Rheumatology Physician, NPI 1912997628
Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
504 RHEUMATOLOGY in TX
Loading map...
Provider Addresses for MR. THOMAS NATHAN HOFFMANN (M.D.)
215, Northridge Drive, Oak Park, San Antonio, Bexar County, Texas, 78209, United States
SAN ANTONIO, TX 782092942
Phone: (210) 701-8453
Type: Mailing
Roger Brooke Drive, San Antonio, Bexar County, Texas, 78219, United States
SAN ANTONIO, TX 782344501
Phone: (210) 916-0797
Fax: (210) 916-5222
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 324 Open Payments records for all available years, with a total value of $7,332.
Total Amount is formed as General ($7,332) + Research ($0) + Ownership ($0) = $7,332.
Last reported payment date: 2024-12-19 • Largest payer in this snapshot: Amgen Inc. ($1,254).
Total Amount
$7,332
General + Research + Ownership
Payments
324
Total payment records
General Amount
$7,332
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-19
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Amgen Inc. | $1,254 |
| UCB, Inc. | $1,201 |
| ABBVIE INC. | $1,123 |
| Janssen Biotech, Inc. | $755 |
| Novartis Pharmaceuticals Corporation | $591 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2020-03-03
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20200303000094 | I | Rheumatology | TX | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 32,800 | 28 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,050 | 20 | $0 |
| J0897 | Injection, denosumab, 1 mg | 2,040 | 25 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 508 | 230 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 180 | 49 | $0 |
Insurance plans in this area (ZIP 78209)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| - | TX | |
| Internal Medicine, Rheumatology | TX | |
| Rheumatology, Internal Medicine | TX |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.